Back to News
Market Impact: 0.18
EpiSign Launches METRIC 5-base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationProduct Launches
EpiSign launched EpiSign METRIC 5-base, software extending automated analysis for more than 300 episignature disorders beyond methylation microarrays to Illumina 5-base, PacBio HiFi and Oxford Nanopore sequencing data. The launch broadens compatibility across major sequencing platforms and could support adoption of epigenomic diagnostic analysis, but no financial metrics, customer commitments, or revenue impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
ILMN0.20
ONT0.35
More News
- Tencent leases 100,000 chips from Oracle for $7 bln- FT
- California Gov. Gavin Newsom bans AI 'robo bosses' in landmark state law, reversing his earlier veto
- RAM supply set to worsen, says Micron, as CEO celebrates ‘much higher’ prices
- Why is Kioxia stock rallying today?
- We're raising our Micron price target after an incredible quarter and robust guidance
- Micron Forecast Tops Estimates on Booming AI Memory Demand